To amend the Controlled Substances Act to prohibit the knowing possession of a pill press mold with intent to manufacture in violation of such Act a counterfeit substance in schedule I or II in a capsule, tablet, and other form intended for distribution, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To amend the Controlled Substances Act to prohibit the knowing possession of a pill press mold with intent to manufacture in violation of such Act a counterfeit substance in schedule I or II in a capsule, tablet, and other form intended for distribution, and for other purposes., changes federal law or congressional policy affecting law enforcement, courts, victims, and regulated public-safety actors. The main policy domain is Criminal Justice, Trade, Immigration.
Who Benefits and How
law enforcement, courts, victims, and regulated public-safety actors may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, law enforcement, courts, victims, and regulated public-safety actors may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H95896EB283404542A8C78D0697530D33: 1. Short title This Act may be cited as the Criminalizing Abused Substance Templates Act of 2024.
- Section H8839A4E920A148C590149119AB7A0A4F: 2. Unlawful possession of pill press molds Section 401 of the Controlled Substances Act (21 U.S.C. 841) is amended by adding at the end the following:...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To amend the Controlled Substances Act to prohibit the knowing possession of a pill press mold with intent to manufacture in violation of such Act a counterfeit substance in schedule I or II in a capsule, tablet, and other form intended for distribution, and for other purposes., changes federal law or congressional policy affecting law enforcement, courts, victims, and regulated public-safety actors.
Key Policy Areas
Criminal Justice, Trade, Immigration
Primary Purpose
This bill, To amend the Controlled Substances Act to prohibit the knowing possession of a pill press mold with intent to manufacture in violation of such Act a counterfeit substance in schedule I or II in a capsule, tablet, and other form intended for distribution, and for other purposes., changes federal law or congressional policy affecting law enforcement, courts, victims, and regulated public-safety actors.
Policy Domains
Whole bill
Identified Gains
- law enforcement, courts, victims, and regulated public-safety actors
Identified Costs
- federal implementing agencies
- law enforcement, courts, victims, and regulated public-safety actors
Sponsors
Legislative Progress
IntroducedMr. Cassidy (for himself and Ms. Hassan) introduced the following …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_commission"
- → The commission identified in the operative section
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology